CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-3.55%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$16B
AUM Growth
-$1.4B
(-8.1%)
Cap. Flow
-$440M
Cap. Flow
% of AUM
-2.76%
Top 10 Holdings %
Top 10 Hldgs %
29.19%
Holding
734
New
51
Increased
199
Reduced
358
Closed
49
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$108M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$77.8M |
| 3 |
Welltower
WELL
|
$52.5M |
| 4 |
Intuitive Surgical
ISRG
|
$50.7M |
| 5 |
Agilent Technologies
A
|
$34.9M |
Top Sells
| 1 |
ALTR
Altair Engineering Inc. Class A Common Stock
ALTR
|
$67M |
| 2 |
UnitedHealth
UNH
|
$45.8M |
| 3 |
Amphenol
APH
|
$42.2M |
| 4 |
Becton Dickinson
BDX
|
$36M |
| 5 |
Eli Lilly
LLY
|
$35.8M |
Sector Composition
| 1 | Technology | 31.51% |
| 2 | Healthcare | 25.4% |
| 3 | Financials | 11.6% |
| 4 | Consumer Discretionary | 7.99% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Truist Financial
TFC
$60B
| $27.2M | 0.17% |
661,258
+90,314
| +16% | +$3.72M |
|
127
GE Vernova
GEV
$158B
| $26.7M | 0.17% |
87,457
-19,990
| -19% | -$6.1M |
|
128
Hologic
HOLX
$14.8B
| $26.6M | 0.17% |
430,141
-514,191
| -54% | -$31.8M |
|
129
Ultragenyx Pharmaceutical
RARE
$3.07B
| $26.4M | 0.17% |
728,017
+53,760
| +8% | +$1.95M |
|
130
Carlisle Companies
CSL
$16.9B
| $26.3M | 0.16% |
77,276
+439
| +0.6% | +$149K |
|
131
Healthcare Realty
HR
$6.35B
| $26.1M | 0.16% |
1,543,440
-186,211
| -11% | -$3.15M |
|
132
Biogen
BIIB
$20.6B
| $25.6M | 0.16% |
186,780
-15,184
| -8% | -$2.08M |
|
133
IQVIA
IQV
$31.9B
| $25.2M | 0.16% |
143,036
-4,867
| -3% | -$858K |
|
134
Veralto
VLTO
$26.2B
| $25.2M | 0.16% |
258,687
-2,881
| -1% | -$281K |
|
135
Banco Santander Chile
BSAC
$12.1B
| $25.1M | 0.16% |
+1,101,600
| New | +$25.1M |
|
136
Nuvalent
NUVL
$5.83B
| $25.1M | 0.16% |
354,129
-13,966
| -4% | -$990K |
|
137
KKR & Co
KKR
$121B
| $24.8M | 0.16% |
214,544
-32,716
| -13% | -$3.78M |
|
138
argenx
ARGX
$45.9B
| $24.4M | 0.15% |
41,280
-6,930
| -14% | -$4.1M |
|
139
United Therapeutics
UTHR
$18.1B
| $24.4M | 0.15% |
79,213
+4,606
| +6% | +$1.42M |
|
140
Equinix
EQIX
$75.7B
| $24.1M | 0.15% |
29,547
-2,034
| -6% | -$1.66M |
|
141
Ralph Lauren
RL
$18.9B
| $24.1M | 0.15% |
79,474
+53,839
| +210% | +$16.3M |
|
142
Stride
LRN
$7.01B
| $23.9M | 0.15% |
189,143
+128,947
| +214% | +$16.3M |
|
143
Marsh & McLennan
MMC
$100B
| $23.4M | 0.15% |
96,023
-4,128
| -4% | -$1.01M |
|
144
Elevance Health
ELV
$70.6B
| $23.4M | 0.15% |
53,831
-20,660
| -28% | -$8.99M |
|
145
Futu Holdings
FUTU
$26.1B
| $23.3M | 0.15% |
227,392
-122,708
| -35% | -$12.6M |
|
146
Revolution Medicines
RVMD
$7.57B
| $23.2M | 0.15% |
655,134
-1,606
| -0.2% | -$56.8K |
|
147
Fortinet
FTNT
$60.4B
| $23.1M | 0.14% |
239,688
+181,434
| +311% | +$17.5M |
|
148
CBRE Group
CBRE
$48.9B
| $22.5M | 0.14% |
172,288
-14,648
| -8% | -$1.92M |
|
149
CME Group
CME
$94.4B
| $22M | 0.14% |
83,044
+14,160
| +21% | +$3.76M |
|
150
Clean Harbors
CLH
$12.7B
| $21.7M | 0.14% |
109,920
-869
| -0.8% | -$171K |
|